Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNONW) EBIT (2021 - 2025)

Historic EBIT for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to -$3.4 million.

  • Tenon Medical's EBIT fell 550.54% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year increase of 462.36%. This contributed to the annual value of -$13.8 million for FY2024, which is 1246.9% up from last year.
  • According to the latest figures from Q3 2025, Tenon Medical's EBIT is -$3.4 million, which was down 550.54% from -$2.9 million recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's EBIT ranged from a high of -$189000.0 in Q1 2021 and a low of -$7.9 million during Q4 2022
  • Moreover, its 5-year median value for EBIT was -$3.3 million (2022), whereas its average is -$3.4 million.
  • Per our database at Business Quant, Tenon Medical's EBIT plummeted by 100000.0% in 2022 and then soared by 6038.09% in 2023.
  • Over the past 5 years, Tenon Medical's EBIT (Quarter) stood at -$2.6 million in 2021, then tumbled by 209.45% to -$7.9 million in 2022, then soared by 60.38% to -$3.1 million in 2023, then fell by 1.02% to -$3.2 million in 2024, then fell by 6.9% to -$3.4 million in 2025.
  • Its EBIT was -$3.4 million in Q3 2025, compared to -$2.9 million in Q2 2025 and -$3.7 million in Q1 2025.